◆ 会议时间：2026年11月10-13日
◆ 会议地点：西班牙 马德里
◆ 会议简介：
2026年第21届国际感染病学大会(ICID2026)将于2026年11月10-13日在西班牙马德里举行，会议由国际感染病学会(ISID)组织，预计有超过2000名专业人士与会。
国际感染病学会(ISID)成立于1986年，由国际感染病大会(ICID)和国际感染病与寄生虫病联合会(IFIPD)合并组建，宗旨是宣改善感染性疾病患者的护理，培训指导感染病学和微生物学临床医生和研究人员以及控制世界各地的感染性疾病等；目前ISID在全球155个国家拥有超过80000名会员。ISID及其成员致力于发展伙伴关系，并寻求全球传染病问题的解决方案。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.
ICID 2026 -
21st International Congress on Infectious Diseases
时间/Date:
November 10-13, 2026
地点/Venue:
Madrid, Spain
Organized by:
International Society for Infectious Diseases (ISID)
摘要征文投稿：
- Abstract submission deadline： 28 April, 2026
- Notifications to submitters will be emailed： by end of June, 2026
点此提交摘要>>>Submit Abstract>>>
Submission
- The presenting author of Orals and Poster presentations are expected to register by the deadline for in-person presentation at the Congress.
- The presenting author is required to ensure that all co-authors are aware of and approve the content of the abstract before submission.
- Maximum abstract submission and presentations per person: 5
- All abstracts submitted via the online submission form before the deadline will be forwarded to the Abstract Review Committee for review.
- An abstract can be submitted if it has not been previously accepted for publication or presented at another Congress before the ICID 2026 Congress dates.
- All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication.
- Abstracts submitted by fax or e-mail will not be accepted.
- Please do not submit multiple copies of the same abstract.
Abstract Title
A brief title that clearly indicates the content of the contribution (maximum of 30 words).
Please avoid abbreviations in the abstract title. Abbreviations may be used if they refer to gene names using the standardized nomenclature, and in the body of the abstract if defined when first used. Do not use capitals or capitalize words that are not nouns.
Example:
Title: This is an important African contribution to the field in terms of the APOL1 gene
Abstract Content
Diagrams, illustrations, tables, references and graphics are NOT permitted.
Abstracts under all topics and without exception should be structured under the following section headings; Aim, Methods, Results, Conclusion (maximum of 300 words).
Check grammar and spelling, sentence construction and punctuation before submission. Ensure that abbreviations are defined when used for the first time and then use the abbreviation in the rest of the abstract. Only use abbreviations if the term is used two or more times.
Note: Abstracts not submitted in the format above will not be eligible for review.
- The abstract should be as informative as possible
- Aim: State background to the study and the aim of the study
- Methods: shortly describe methods used
- Results: summarize results obtained, report quantitative data, confidence intervals, and p values for comparisons
- Conclusions: state conclusions reached
Presentation type – please choose from one of the following:
- Oral presentation
- Poster presentation
Author and co-authors’ details:
- Full first and family name(s)
- Affiliation details: department, institution / hospital, city, state (if relevant), country
Abstract topic – Abstracts must be allocated to a specific topic for the Scientific Program. Please choose from the list of topics.
Abstract may be reallocated by the scientific committee, in order to organize consistent sessions
Late Breaking Abstract
Late Breaking abstract submission will be between 4-18 August, 2026. Please note: late-breaking abstract submission is not an extension to the regular submission, but this abstract should contain new information with results that were not yet known\fully available on the regular abstract submission deadline.
These abstracts must include new decisive and original results obtained after the submission deadline. The justification of the late breaking must be added as a commentary upon submission
Dear Colleagues,
On behalf of the International Society for Infectious Diseases (ISID), it is our distinct honor to invite you to the 21st International Congress on Infectious Diseases (ICID 2026), which will be held in the vibrant city of Madrid, Spain, from November 10–13, 2026.
Since its inception more than two decades ago, the ICID has served as a globally recognized platform for advancing science, clinical practice, and public health policy in the field of infectious diseases. Each congress has marked new milestones, whether unveiling pivotal research outcomes, informing pandemic preparedness, or fostering the next generation of leaders in global health. Building on this legacy, ICID 2026 promises to be a landmark event that both reflects on transformative progress and looks ahead to emerging challenges.
The scientific programme will feature plenary lectures from internationally renowned experts, in-depth symposia, interactive workshops, and state-of-the-art poster sessions, designed to highlight the latest breakthroughs in microbial pathogenesis, vaccine development, antimicrobial resistance, zoonotic and emerging infections, digital health innovations, and strategies to advance health equity worldwide.
By bringing together scientists, clinicians, epidemiologists, policymakers, and community stakeholders, ICID 2026 in Madrid is designed to spark collaborations that turn research into practical, global health solutions, set within a city whose vibrant cultural heritage and history of scientific exchange reflect the energy and diversity of our field. This Congress provides a vital forum for all attendees from seasoned investigators and public health leaders to veterinarians, industry partners, and early-career professionals to share knowledge, forge partnerships, and collectively guide the future of infectious disease prevention and care.
We look forward with great anticipation to welcoming you to Madrid for what promises to be an unforgettable and transformative gathering of the infectious disease community.
With warm regards,
Dr Sally Roberts
President, ISID
◆ 参会对象：
成人和儿童感染病专家、微生物学和病毒学实验室专家，公共卫生专家和流行病学家，感染预防和控制从业人员，药剂师，在同一健康领域工作的兽医和环境卫生从业人员，各级传染病、微生物学和病毒学研究员和受训人员、传染病研究科学家和受训人员、全科医生、内科医生、肺病和重症护理医师以及其他护理传染病患者的人员， 政策制定者，护士，学生，企业代表等等。
|
